Torii Pharmaceutical Co Ltd
TSE:4551
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HAKI Safety AB
STO:HAKI B
|
SE |
|
Vizio Holding Corp
NYSE:VZIO
|
US |
|
Nfon AG
XETRA:NFN
|
DE |
|
C
|
Corning Inc
XETRA:GLW
|
US |
|
Pansoft Co Ltd
SZSE:300996
|
CN |
|
M
|
Mountview Estates PLC
LSE:MTVW
|
UK |
|
China Foods Ltd
HKEX:506
|
HK |
|
Shenzhen Noposion Agrochemicals Co Ltd
SZSE:002215
|
CN |
|
T
|
Triveni Glass Ltd
BSE:502281
|
IN |
|
A
|
Allianz Malaysia Bhd
KLSE:ALLIANZ
|
MY |
|
Alamo Group Inc
NYSE:ALG
|
US |
|
Gree Electric Appliances Inc of Zhuhai
SZSE:000651
|
CN |
Torii Pharmaceutical Co Ltd
Inventory
Torii Pharmaceutical Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Torii Pharmaceutical Co Ltd
TSE:4551
|
Inventory
¥17.3B
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
5%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Inventory
¥1.4T
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Inventory
¥651.2B
|
CAGR 3-Years
35%
|
CAGR 5-Years
29%
|
CAGR 10-Years
16%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Inventory
¥374.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Inventory
¥276.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Inventory
¥330B
|
CAGR 3-Years
26%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
Torii Pharmaceutical Co Ltd
Glance View
Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.
See Also
What is Torii Pharmaceutical Co Ltd's Inventory?
Inventory
17.3B
JPY
Based on the financial report for Jun 30, 2025, Torii Pharmaceutical Co Ltd's Inventory amounts to 17.3B JPY.
What is Torii Pharmaceutical Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
5%
Over the last year, the Inventory growth was 45%. The average annual Inventory growth rates for Torii Pharmaceutical Co Ltd have been 25% over the past three years , 18% over the past five years , and 5% over the past ten years .
